Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products

    loading  Checking for direct PDF access through Ovid

Abstract

Current European pharmaceutical legislation is not adequate to meet advances in science and technologies that will lead to rapid development of custom-made medicines. Using existing legislation for custom-made medical devices as a template and anti-sense oligonucleotides as model medicinal products, we propose new European pharmaceutical legislation to permit timely access to custom-made anti-sense oligonucleotide medicinal products. The proposals may be more widely applicable to other medicinal products.

Related Topics

    loading  Loading Related Articles